ARTICLE | Clinical News
Lebrikizumab: Phase III data
March 7, 2016 8:00 AM UTC
Top-line data from the identical, double-blind, international Phase III LAVOLTA I and LAVOLTA II trials in >2,100 patients total with severe uncontrolled asthma despite treatment with inhaled corticos...